Peptide storage and shelf life: what the research actually shows

The two shelf lives

There is no such thing as a single "shelf life" for a peptide. There are two — the lyophilized shelf life and the reconstituted shelf life — and they typically differ by one to two orders of magnitude. The cake of dry powder inside a sealed vial is one of the most stable forms a protein can exist in. The clear solution that same powder becomes once you add water is one of the least.

Wang's 2000 review in the International Journal of Pharmaceutics — still the most cited paper on lyophilized protein pharmaceuticals — laid out the basic physics. In the dry state, water content is below the threshold needed for most hydrolytic reactions to proceed, molecular mobility is suppressed, and the peptide is locked into a glassy matrix that protects it from the conformational changes that lead to aggregation and degradation. Lyophilized peptides held at the correct temperature can remain stable for years. Once water is added back, the peptide is suddenly in solution again, surrounded by reactive water molecules, in contact with air, at a concentration ideal for dimerization — and the clock starts running in days and weeks rather than months and years.

Every storage decision flows from this single asymmetry. The longer a peptide spends as a powder, the better. The shorter it spends in solution, the better.

Temperature: the three operating points

There are three temperatures worth thinking about, and each is appropriate for a different state of the peptide.

• Room temperature (20–25 °C). Acceptable only for short-term holding of unopened lyophilized vials in transit. Most manufacturers' stability data shows minimal degradation over a few weeks at room temperature in the dry state, but the rate of degradation accelerates substantially as you climb past 25 °C. Not a long-term storage option.
• Refrigerator (2–8 °C). The standard for both lyophilized vials in regular use and reconstituted vials. The 5 °C window is cold enough to slow chemical degradation by roughly half compared to room temperature (rule of thumb: reaction rates roughly double per 10 °C of warming) and warm enough to avoid the freezing problems described below.
• Freezer (-20 °C, occasionally -80 °C). Appropriate for long-term storage of lyophilized peptide only. A lyophilized cake is already below the moisture threshold that causes ice damage; freezing it just locks in that state. Manning et al. (1989, updated 2010) note that frozen lyophilized formulations can remain stable for many years if protected from moisture ingress through the stopper.

The reason the freezer is not appropriate for reconstituted peptides is that ice crystal formation during freezing physically disrupts protein structure. Carpenter and colleagues (1997) detailed the mechanism in their canonical formulation paper: as water freezes into ice, solutes are concentrated into the remaining liquid phase, pH shifts can occur, and the peptide is subjected to mechanical stress at the ice interface. With each freeze-thaw cycle, a fraction of the peptide misfolds, aggregates, or loses activity. Pharmaceutical formulations include cryoprotectants (often sucrose or trehalose) precisely to mitigate this. Reconstituted peptide-plus-bacteriostatic-water has no such protection.

A short-form rule: fridge for in-use, freezer for unopened lyophilized only, never freeze anything that has been reconstituted.

Light, oxygen, and the small everyday insults

Beyond temperature, the published stability literature identifies a few other environmental insults that matter at the timescale of weeks to months.

• Ultraviolet and visible light can drive photo-oxidation of tryptophan, tyrosine, and methionine residues, the most light-sensitive amino acids. For peptides containing these residues — most do — direct sunlight exposure is meaningfully damaging. Amber glass vials filter most of the relevant wavelengths and most peptides are sold in them. If the vials are clear, foil wrapping or storage in an opaque container does the same job.
• Dissolved oxygen drives oxidation of methionine and cysteine residues. This is one reason reconstituted vials degrade faster than dry powder, and one reason aggressive shaking — which beats oxygen into solution — is discouraged. Slow, gentle swirling is the published standard.
• Adsorption to surfaces is a real but usually small factor: a fraction of peptide will stick to glass and plastic surfaces (syringe barrels, vial walls). This matters most for very dilute solutions and very small total amounts of peptide. For typical peptide concentrations (mg/mL range), the loss is negligible.

Bacteriostatic water and the 28-day rule

Bacteriostatic water for injection is sterile water containing 0.9% benzyl alcohol as a bacteriostatic preservative. The benzyl alcohol does not eliminate microbial contamination; it prevents the growth of any organisms introduced through repeated stopper punctures. This is what makes a multi-dose reconstituted vial possible at all.

The USP monograph for bacteriostatic water specifies that, once the seal of the bottle has been broken (first puncture), the contents are considered usable for up to 28 days, regardless of how much remains. The same 28-day window is conventionally applied to reconstituted peptide vials prepared with bacteriostatic water — not because the peptide itself is necessarily unstable past 28 days, but because the preservative cannot be relied on to suppress contamination indefinitely.

For peptides whose own published stability in solution is less than 28 days, the peptide-specific limit governs. For peptides stable longer than 28 days in solution, the bacteriostatic water limit governs. In practice, almost every common peptide reconstituted with bacteriostatic water lands at the 28-day mark for one reason or the other.

A note: sterile water for injection (no preservative) cuts the in-use window to one use, then discard. It is the right diluent only when the entire vial will be drawn into a syringe in a single sitting, which is rare for multi-dose peptide use.

Specific stability windows for common peptides

The numbers below are drawn from a combination of manufacturer stability data, the FDA labels of approved analogs, and published research on closely related compounds. They are reasonable working defaults — not guarantees, and not specific to any one supplier's formulation.

Peptide	Lyophilized (refrigerated)	Reconstituted (refrigerated)
BPC-157	24+ months	28 days
TB-500	24+ months	28 days
GHK-Cu	12–24 months (light-protected)	14–28 days
Ipamorelin / CJC-1295 (no DAC)	24+ months	28 days
Semaglutide (compounded lyo)	24 months	28 days (per branded label, refrigerated)
Tirzepatide (compounded lyo)	24 months	28 days

The branded Ozempic FDA label is instructive as a benchmark: it specifies that an in-use pen may be kept at room temperature or refrigerated for up to 56 days — twice the 28-day rule — because the formulation is preserved differently than bacteriostatic-water reconstitution. The same does not transfer to compounded vials.

How to actually tell if a peptide has gone bad

Most peptide degradation is invisible. A peptide can lose half its activity through deamidation, oxidation, or partial aggregation without any change you can see by holding the vial up to a light. That said, a few signs do reliably indicate damage:

• Cloudiness or suspended particles in a previously clear solution. This is aggregation, and it is almost always the end of usable life.
• Yellowing or browning of a previously colorless solution. Some Maillard-type reactions can discolor a peptide solution. (GHK-Cu is an exception — it is naturally blue-to-teal due to the copper ion, and a fading of color toward clear indicates degradation.)
• A new smell of the contents. Healthy reconstituted peptide should smell like bacteriostatic water — faintly alcoholic from the benzyl alcohol, otherwise nothing. A sour, sulfurous, or yeasty smell suggests contamination.
• A loss of expected effect at the same dose. The most sensitive detector you have, in the absence of an HPLC. If a dose that consistently produced a response stops doing so, the most likely explanation is potency loss, not tolerance.

Conversely, the fact that a solution looks fine does not prove anything. Visual inspection catches the worst failures, not the subtle ones.

The freeze-thaw problem in practical terms

A specific failure mode worth highlighting: people sometimes store reconstituted vials in the freezer "to extend shelf life." The intuition is reasonable — colder is more stable in chemistry, generally — but it is wrong for reconstituted peptides. Each freeze-thaw cycle physically disrupts the peptide. Two cycles, and a meaningful fraction of activity is gone. Five cycles, and the activity loss is severe and unpredictable.

This is also why a vial that has accidentally been left in a hot car, or a fridge that froze its lower shelves, should be regarded with suspicion. A single freeze of a reconstituted vial is not catastrophic for most peptides, but it is not nothing.

The corollary: if you genuinely need long-term storage, do it with unreconstituted vials at -20 °C or colder. The dry cake takes freezing in stride.

Travel: gel packs, TSA, and dry ice

Short trips (under 24 hours total transit) with reconstituted vials are generally fine in a soft cooler with a couple of frozen gel packs. The TSA does not impose a volume limit on medications, including bacteriostatic water and reconstituted peptide vials in carry-on luggage, but you must declare them at the screening checkpoint. A printed copy of any prescribing documentation simplifies this.

Longer trips, or trips where the vials will be exposed to high ambient temperatures, justify a hard-sided cooler with dedicated gel packs and a thermometer strip. Some travelers carry only lyophilized vials and a small bottle of bacteriostatic water, and reconstitute at the destination. This is the most stable option by a comfortable margin.

Dry ice shipping is what suppliers use for international transit, and it works because the vial never thaws. For consumer travel, dry ice is overkill and introduces its own logistics problems (sublimation, airline restrictions); ordinary refrigerated gel-pack transit is sufficient for anything under a week.

A storage decision tree

A plain-text version of the decision flow:

Is the vial reconstituted?
├── No (lyophilized cake intact)
│   ├── In current use within next ~3 months? → Refrigerator (2–8 °C)
│   └── Long-term hold (>3 months)? → Freezer (-20 °C), light-protected
│
└── Yes (already in solution)
    ├── Will finish within reconstituted stability window? → Refrigerator
    │   └── Label: date reconstituted + concentration + 28-day expiry
    └── Cannot finish in time?
        ├── Use a smaller vial next time, or
        ├── Reconstitute at higher concentration (less water), or
        └── Accept the loss; do not freeze reconstituted material

Two principles fall out of this tree. First, plan your reconstitution to match your usage pattern — a small vial reconstituted at a concentration that lets you finish it within 28 days, rather than a large vial that will sit half-used. Second, label everything the moment it is reconstituted: date, concentration, expiry. Three vials in the fridge a month from now all look identical, and memory is the most failure-prone storage system you have.

What Vial tracks for you

For every active vial, Vial records the reconstitution date, the diluent volume, the resulting concentration, and the projected stability window. The vial card surfaces "days remaining" prominently, and the app sends a heads-up before the window closes so the next vial can be queued. None of this changes the underlying chemistry. It just removes the failure mode where the actual question — when did I open this one? — was answered by guessing.